Intended Use

The EyeBOX is intended to measure and analyze eye movements as an aid in the diagnosis of concussion (mild traumatic brain injury) in patients 5 through 67 years of age in conjunction with a standard neurological assessment of concussion. It provides a BOX score to indicate likelihood of concussion within one week of injury.

Technology

The device consists of a host PC with touchscreen, eye tracking camera with a high-speed near-infrared sensor recording gaze position 500 times per second, a stimulus LCD screen, and head stabilization hardware. It uses a data processing algorithm that analyzes recorded eye movement data to detect subtle changes indicative of concussion. It produces a diagnostic BOX score and additional eye-tracking and pupillometry metrics compared against a normative database.

Performance

Performance testing included software verification, user acceptance testing, normative database testing, and output report metric validation. Accuracy and precision of eye-tracking metrics (gaze position, pupil size, blink detection) were confirmed. Test-retest reliability was evaluated with 30 healthy individuals, demonstrating reproducibility of the metrics. Added eye-tracking parameters did not negatively impact device accuracy or safety.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    7/19/2024

    8 months
  • 2

    FDA Approval

    4/4/2025

Other devices from Oculogica, Inc.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.